![Marc Bozec](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Bozec
Chief Executive Officer at
OSE IMMUNOTHERAPEUTICS
Profile
Marc Le Bozec is the founder of BioProtein Technologies SA, founded in 1998.
Current jobs include Chief Executive Officer at OSE Immunotherapeutics SA starting in 2025 and Independent Director at Nicox SA starting in 2024.
Former job includes Director at CYTOO SA from 2013 to 2015.
Education includes an undergraduate degree from École des Hautes Études Commerciales de Paris.
Marc Bozec active positions
| Companies | Position | Start |
|---|---|---|
| NICOX SA | Director/Board Member | 15/07/2024 |
| OSE IMMUNOTHERAPEUTICS | Chief Executive Officer | 01/10/2025 |
Former positions of Marc Bozec
| Companies | Position | End |
|---|---|---|
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Director/Board Member | 31/12/2014 |
BioProtein Technologies SA
 BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Founder | - |
Training of Marc Bozec
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Health Technology |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
- Stock Market
- Insiders
- Marc Bozec
Choose MarketScreener 
